Status:

COMPLETED

Minocycline's Effects on Alcohol Responses in Humans

Lead Sponsor:

Yale University

Collaborating Sponsors:

United States Department of Defense

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Conditions:

Alcohol Dependence

Eligibility:

All Genders

21-50 years

Phase:

PHASE1

Brief Summary

This is a double-blind, placebo-controlled, outpatient study with a between-groups design. Sixty male and female heavy social drinkers will be randomly assigned to minocycline (200 or 400 mg/day) or p...

Eligibility Criteria

Inclusion

  • Male and females, between the ages of 21 and 50;
  • Heavy social drinkers who are defined as consuming ≥10 standard alcoholic drinks per week with one to five weekly "binge" drinking episodes, (5 plus drinks per occasion for men; 4 plus drinks for women). No maximum level of alcohol consumption will be defined a priori but individuals who met current DSM -IV criteria for AUD will be excluded from the study;
  • No current drug use disorder of any drugs of abuse (except alcohol and tobacco);
  • No current medical problems and normal ECG; 5) For women, not pregnant as determined by pregnancy screening nor breast feeding, and using acceptable birth control methods.

Exclusion

  • Current major psychiatric illnesses including mood, psychotic, or anxiety disorders;
  • History of major medical illnesses; including liver diseases, heart disease, chronic pain or other medical conditions that the physician investigator deems contraindicated for the subject to be in the study;
  • Liver function tests (ALT or AST) greater than 3 times normal;
  • Allergy to minocycline or other tetracyclines;
  • Participants who at any appointment have a Clinical Institute Withdrawal Assessment Scale (CIWA) \[36, 37\] score of 4 or greater, or who report any history of alcohol withdrawal within the past 6 months.

Key Trial Info

Start Date :

July 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2018

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT02187211

Start Date

July 1 2015

End Date

November 1 2018

Last Update

March 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Connecticut Healthcare System

West Haven, Connecticut, United States, 06516